AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
176 hedge funds and large institutions have $2.96B invested in Aerie Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 75 increasing their positions, 45 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more capital invested
Capital invested by funds: $2.94B → $2.96B (+$11.6M)
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
Holders
176
Holding in Top 10
10
Calls
$26.2M
Puts
$15.8M
Top Buyers
| 1 | +$85M | |
| 2 | +$65M | |
| 3 | +$29.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$26.9M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$17.4M |
Top Sellers
| 1 | -$40.9M | |
| 2 | -$28.4M | |
| 3 | -$19M | |
| 4 |
HM
HealthCor Management
New York
|
-$17.4M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$9.23M |